NASDAQ · PRVA
Privia Health Group, Inc.
Healthcare · Medical - Healthcare Information Services
$21.48▼ 2.34% ($0.51)at close
As of 4:00 PM ET
Valuation
Revenue & margin DCF
Verdict: cheap. Price below all scenarios.
No revenue growth rate matches $21.48 with these assumptions.
Check the assumptions or the price used.
Value per share
Base case
$2,679.54
Price used $21.48 is 99% below this
USD · TTM ending Jun 30, 2026 · Price Oct 30, 8:00 PM UTC
The discount rate uses the model's minimum bound. Limited beta or capital-structure data may affect this estimate.
1 more note
This estimate is at least 3× the price used. Review the growth, margin and investment assumptions behind the gap.
Revenue each value needs
Revenue today $2.4B. Base case: $8.6B. At its recent pace: $16.9B. Bear to Bull: $6.1B to $11.7B.
Revenue today $2.4B. Base case: $8.6B. At its recent pace: $16.9B. Bear to Bull: $6.1B to $11.7B.
Revenue in 2036
today $2.4B
Value per share · Base case
$2,679.54
Price $21.48
99% below this
- 10-yr revenue CAGR
- 13.9%
- Ending operating margin
- 2.8%
- Discount rate
- 5.4%
The discount rate uses the model's minimum bound. Limited beta or capital-structure data may affect this estimate.
1 more note
This estimate is at least 3× the price used. Review the growth, margin and investment assumptions behind the gap.
USD · TTM ending Jun 30, 2026 · Price Oct 30, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 12.36% over the last year. Revenue grew 24.1% over the trailing twelve months. Operating margin moved from 1.03% to 1.9%. Free cash flow declined 152.53% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 1.9%. A decisive move in revenue — currently up 24.1% — would be the clearest signal to resolve the ambiguity.
Return analysis
Company profile
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States.
Market multiples
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
20
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 5, 2026
Q3 FY26 · EPS est $0.09 · Revenue est $610.7M
Same quarter, year over year
FY26 YTD +80.0%Each cell vs the same quarter a year earlier (the cell below) · Q1–Q2 combined $0.09 vs $0.05 · 1 of 2 quarters up
Q1
Q2
Q3
Q4
FY total
FY26
—
—
FY25
FY24
FY23
—
—
—
Fiscal year totals
- FY25
- $0.17
- +54.5%
- FY24
- $0.11
- —
Q2 FY26
Reported Aug 6, 2026 · Latest
HoverTap a cell to inspect
Actual
$0.07
Estimate
$0.07
Year over year
+250.0%
Vs prior quarter
+250.0%
Institutional Sentiment
Privia Health Group, Inc. · PRVA
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.